**5. Conclusions**

The results of the present clinical trial suggest that miRNA may be predictors of dental implants clinical outcomes and may be used as biomarkers for diagnostic and prognostic purposes in the field of implant dentistry.

**Author Contributions:** Conceptualization, M.M., P.P. (Paolo Pera)Paolo Pera, D.B. and A.I.; methodology, M.M., D.B. and A.I.; software, A.I. and G.C.V.; validation, M.M., P.P.(Paolo Pesce), D.B. and A.I.; formal analysis, M.M., P.P. (Paolo Pesce) and A.I.; investigation, M.M., P.P. (Paolo Pesce), D.B., G.C.V. and A.I.; resources, P.P.(Paolo Pera) and A.I.; data curation, P.P. (Paolo Pesce) and M.M.; writing—original draft preparation, M.M. and A.I.; writing—review and editing, M.M., A.I. and P.P. (Paolo Pesce); visualization, M.M., A.I. and P.P. (Paolo Pesce); supervision, P.P. (Paolo Pera); project administration, M.M.; funding acquisition, M.M. and P.P. (Paolo Pera).

**Funding:** This research was partly funded by an Atheneum Research Project—PRA 2012, University of Genoa, Genoa, Italy, and by Biomet 3i, Palmbeach Gardens, FL.

**Conflicts of Interest:** The authors declare no conflict of interest.
